FOXP2-Related Syndrome
Table of contents
- What is FOXP2-related syndrome?
- Key Role
- Symptoms
- What causes FOXP2-related syndrome?
- Why does my child have a change in the FOXP2 gene?
- What are the chances that other family members or future children will have FOXP2-related syndrome?
- How many people have FOXP2-related syndrome?
- Do people who have FOXP2-related syndrome look different?
- How is FOXP2-related syndrome treated?
- Behavior and development concerns linked to SNAP25-related syndrome
- Medical and physical concerns linked to HNRNPC-related syndrome
- Where can I find support and resources?
- Sources and References
FOXP2-related syndrome is also called speech-language disorder 1 (SPCH1). For this webpage, we will be using the name FOXP2-related syndrome to encompass the wide range of variants observed in the people identified.
What is FOXP2-related syndrome?
FOXP2-related syndrome happens when there are changes in the FOXP2 gene. These changes can keep the gene from working as it should.
Key Role
The FOXP2 gene plays a key role in controlling other genes in the brain.
Symptoms
Because the FOXP2 gene is important for brain activity, many people who have FOXP2-related syndrome have:
- Developmental delay
- Learning difficulties
- Autism spectrum disorder or features of autism
- Speech impairment, such as childhood apraxia of speech
- Sleep challenges
- Anxiety
- Depression
What causes FOXP2-related syndrome?
FOXP2-related syndrome is a genetic condition, which means that it is caused by variants in genes. Our genes contain the instructions, or code, that tell our cells how to grow, develop, and work. Every child gets two copies of the FOXP2 gene: one copy from their mother’s egg, and one copy from their father’s sperm. In most cases, parents pass on exact copies of the gene to their child. But the process of creating the egg or sperm is not perfect. A change in the genetic code can lead to physical issues, developmental issues, or both.
Sometimes a spontaneous variant happens in the sperm, egg or after fertilization. When a brand new genetic variant happens in the genetic code is called a ‘de novo’ genetic variant. The child is usually the first in the family to have the genetic variant.
De novo variants can take place in any gene. We all have some de novo variants, most of which don’t affect our health. But because FOXP2 plays a key role in development, de novo variants in this gene can have a meaningful effect.
Research shows that FOXP2-related syndrome is often the result of a de novo variant in FOXP2. Many parents who have had their genes tested do not have the FOXP2 genetic variant found in their child who has the syndrome. In some cases, FOXP2-related syndrome happens because the genetic variant was passed down from a parent.
Autosomal dominant conditions
FOXP2-related syndrome is an autosomal dominant genetic condition. This means that when a person has the one damaging variant in FOXP2 they will likely have symptoms of FOXP2-related syndrome. For someone with an autosomal dominant genetic syndrome, every time they have a child there is a 50 percent chance they pass on the same genetic variant and a 50 percent chance they do not pass on the same genetic variant.
Autosomal Dominant Genetic Syndrome
Why does my child have a change in the FOXP2 gene?
No parent causes their child’s FOXP2-related syndrome. We know this because no parent has any control over the gene changes that they do or do not pass on to their children. Please keep in mind that nothing a parent does before or during the pregnancy causes this to happen. The gene change takes place on its own and cannot be predicted or stopped.
What are the chances that other family members or future children will have FOXP2-related syndrome?
Each family is different. A geneticist or genetic counselor can give you advice on the chance that this will happen again in your family.
The risk of having another child who has FOXP2-related syndrome depends on the genes of both biological parents.
- If neither biological parent has the same genetic variant found in their child, the chance of having another child who has the syndrome is on average 1 percent. This 1 percent chance is higher than the chance of the general population. The increase in risk is due to the very unlikely chance that more of the mother’s egg cells or the father’s sperm cells carry the same genetic variant.
- If one biological parent has the same genetic variant found in their child, the chance of having another child who has the syndrome is 50 percent.
For a symptom-free brother or sister of someone who has FOXP2-related syndrome, the sibling’s risk of having a child who has FOXP2-related syndrome depends on the sibling’s genes and their parents’ genes.
- If neither parent has the same genetic variant causing FOXP2-related syndrome, the symptom-free sibling has a nearly 0 percent chance of having a child who would inherit FOXP2-related syndrome.
- If one biological parent has the same genetic variant causing FOXP2-related syndrome, the symptom-free sibling has a 50 percent chance of also having the same genetic variant. If the symptom-free sibling has the same genetic variant, their chance of having a child who has the genetic variant is 50 percent.
For a person who has FOXP2-related syndrome, the risk of having a child who has the syndrome is about 50 percent.
How many people have FOXP2-related syndrome?
As of 2026, about 66 people with FOXP2-related syndrome have been identified in a medical clinic.
Do people who have FOXP2-related syndrome look different?
People who have FOXP2-related syndrome might not look very different.
How is FOXP2-related syndrome treated?
Scientists and doctors have only just begun to study FOXP2-related syndrome. At this point, there are no medicines designed to treat the syndrome. A genetic diagnosis can help people decide on the best way to track the condition and manage therapies. Doctors can refer people to specialists for:
-
- Physical exams and brain studies
- Genetics consults
- Development and behavior studies
- Other issues, as needed
A developmental pediatrician, neurologist, or psychologist can follow progress over time and can help:
-
- Suggest the right therapies. This can include physical, occupational, speech, or behavioral therapy.
- Guide individualized education plans (IEPs).
Specialists advise that therapies for FOXP2-related syndrome should begin as early as possible, ideally before a child begins school.
If seizures happen, consult a neurologist. There are many types of seizures, and not all types are easy to spot. To learn more, you can refer to resources such as the Epilepsy Foundation’s website: www.epilepsy.com/learn/types-seizures.
This section includes a summary of information from major published articles. It highlights how many people have different symptoms. To learn more about the articles, see the Sources and References section of this guide.
Behavior and development concerns linked to SNAP25-related syndrome
Learning and Speech
Some people with FOXP2-related syndrome had developmental delay or intellectual disability, and several had learning disabilities. Most people had speech delay and speech challenges as they aged, including impairment of expressive and receptive language abilities, verbal dyspraxia, having only a few words for communication, stuttering, and articulation issues. People usually developed their first words between 18 months and 7 years.
- 8 out of 40 people had developmental delay or intellectual disability (20 percent)
- 12 out of 24 people had learning disabilities (50 percent)
- 32 out of 37 people had speech delay (87 percent)
- 9 out of 24 people had articulation issues (38 percent)
Graphs
100%
80%
60%
40%
20%
0
Often people had a non-verbal IQ that was higher than their verbal IQ, and most people attended mainstream schooling. Many people had learning support in school, such as a teaching aide and an individualized learning plan.
- 14 out of 23 people attended mainstream schooling (61 percent)
Graphs
Behavior
A few people with FOXP2-related syndrome had behavioral challenges, such as autism or features of autism, attention-deficit/hyperactivity disorder (ADHD), restricted interests and behavior, anxiety, depression, and obsessive-compulsive disorder.
- 8 out of 40 people had autism (20 percent)
- 5 out of 27 people had anxiety (19 percent)
- 6 out of 27 people had depression (22 percent)
- 2 out of 27 people had obsessive-compulsive disorder (7 percent)
Graphs
100%
80%
60%
40%
20%
0
Medical and physical concerns linked to HNRNPC-related syndrome
Other medical features
More than 1 in 3 people with FOXP2-related syndrome had feeding difficulties as babies. Some had gross motor and fine motor impairments, sleep issues, hearing issues, low muscle tone, and a smaller than average head size (microcephaly).
- 10 out of 26 people had feeding difficulties (38 percent)
- 13 out of 26 people had gross motor impairments (50 percent)
- 13 out of 26 people had fine motor impairments (50 percent)
- 10 out of 24 people had sleep issues (42 percent)
- 2 out of 26 people had hearing issues (8 percent)
Where can I find support and resources?
Simons Searchlight
Simons Searchlight is an online international research program, building an ever growing natural history database, biorepository, and resource network of over 175 rare genetic neurodevelopmental disorders. By joining their community and sharing your experiences, you contribute to a growing database used by scientists worldwide to advance the understanding of your genetic condition. Through online surveys and optional blood sample collection, they gather valuable information to improve lives and drive scientific progress. Families like yours are the key to making meaningful progress. To register for Simons Searchlight, go to the Simons Searchlight website at www.simonssearchlight.org and click “Join Us.”
- Learn more about Simons Searchlight – www.simonssearchlight.org/frequently-asked-questions
- Simons Searchlight webpage with more information on FOXP2 – www.simonssearchlight.org/research/what-we-study/foxp2
Sources and References
- Che, F., Li, C., Zhang, L., Qian, C., Mo, L., Li, B., Wu, H., Wang, L., & Yang, Y. (2024). Novel FOXP2 variant associated with speech and language dysfunction in a Chinese family and literature review. Journal of Applied Genetics, 65(2), 367-373. doi:10.1007/s13353-024-00849-0 [correction: 10.1007/s13353-024-00851-6]
- Morgan, A., Fisher, S. E., Scheffer, I., & Hildebrand, M. FOXP2-related speech and language disorder. 2023 Jan 26. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK368474/
- Morison, L. D., Meffert, E., Stampfer, M., Steiner-Wilke, I., Vollmer, B., Schulze, K., Briggs, T., Braden, R., Vogel, A., … & Morgan, A. T. (2023). In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting FOXP2. Journal of Medical Genetics, 60(6), 597-607. doi:10.1136/jmg-2022-108734